...
 Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation

Assessment first
Hormone-free option
Safety focused

Women’s Health Clinic FAQ

What happens during a polynucleotide treatment?

Intimate polynucleotides are non-hormonal biostimulatory treatments used in some clinics for vulvovaginal tissue quality. The important first step is confirming the symptom cause, not choosing an injectable by name.

Direct answer

A polynucleotide treatment should begin with consultation, diagnosis, consent and product explanation before any injection is performed. The clinician should check symptoms, medical history, fish allergy, infection, bleeding risk, pregnancy status and realistic goals. On treatment day, the area is cleansed, topical anaesthetic may be applied, and small targeted injections are placed into the planned tissue layer. Aftercare should cover hygiene, pelvic rest, bruising, swelling and when to seek help.

Your clinician should review symptoms, medical history, allergies, medicines, cancer history where relevant, alternatives, expected benefits, limitations and aftercare before deciding whether treatment fits.

Educational only. Suitability must be confirmed after consultation and assessment. Results vary. Not a cure.

Women's Health Clinic consultation about What happens during a polynucleotide treatment?
Consultation-led care

At a glance

These are the main points to understand before deciding whether intimate polynucleotides are suitable.

Polynucleotides at a glance

Non-hormonal biostimulation

Origin

Derived from highly purified marine DNA (trout or salmon).

Mechanism

Activates fibroblasts, improves microcirculation, reduces inflammation, and binds water molecules for deep hydration.

Primary Uses

Skin texture improvement, acne scarring, rosacea, periocular (under-eye) rejuvenation, and intimate wellness (treating vaginal dryness and dyspareunia).

Safety Profile

Highly biocompatible and rigorously purified to remove proteins, virtually eliminating the risk of immunogenic (allergic) reactions in non-allergic patients.

Important safety note

Absolute Contraindications: Individuals with a severe fish or shellfish allergy must avoid this treatment due to its marine derivation.

Diagnosis
Allergy
Evidence
Aftercare
Alternatives




Detailed answer

Step by step care

A good appointment moves from assessment and consent to cleansing, numbing, small injections and aftercare.

Procedure detail builds trust

Patients need realistic sensory detail and clear aftercare, not just “quick and easy” language.

Mechanism
Evidence
Symptoms
Alternatives

What it means

Regenerative Primer: In modern aesthetics, polynucleotides are increasingly used as a biological 'primer' to condition the extracellular matrix prior to the application of dermal fillers, RF microneedling, or exosome therapies.

Why symptoms matter

Intimate Wellness Adjunct: For GSM, polynucleotides are not a first-line definitive treatment but an advanced adjunct therapy.

Evidence limits

Evidence is encouraging in selected areas, but intimate-use claims should remain cautious and assessment-led.

Treatment fit

Administration: The procedure is performed in an outpatient clinical setting and involves multiple micro-injections into the superficial dermal layers using a very fine needle.

What this means in practice

Administration: The procedure is performed in an outpatient clinical setting and involves multiple micro-injections into the superficial dermal layers using a very fine needle.

Initial Protocol: A standard clinical course requires 2 to 3 sessions for skin treatments, and up to 5 sessions for intimate wellness, spaced 2 to 4 weeks apart.





Patient safety

Why diagnosis comes first

Many intimate symptoms overlap. The right treatment depends on whether the issue is GSM, infection, vulval skin disease, scarring, pelvic-floor guarding, medication effect or another cause.

It checks the cause

Regenerative Primer: In modern aesthetics, polynucleotides are increasingly used as a biological 'primer' to condition the extracellular matrix prior to the application of dermal.

It protects safety

Absolute Contraindications: Individuals with a severe fish or shellfish allergy must avoid this treatment due to its marine derivation.

It reviews alternatives

Moisturisers, lubricants, local ooestrogen, pelvic-floor care or specialist review may be more appropriate first.

It sets expectations

Polynucleotides are gradual tissue-support treatments, not instant resolves or promised outcomes.

Non-hormonal does not mean automatic

A hormone-free option may still be unsuitable if there is infection, unexplained bleeding, pregnancy, recent surgery, severe fish allergy or unclear pelvic pain.

Good care explains product source, treatment route, alternatives, limits, aftercare and when another medical pathway is safer.





Considerations

What to consider

Treatment planning should include diagnosis, symptom pattern, allergy risk, medicines, consent, realistic timelines and aftercare.

Consultation priorities

A consultation should review symptoms, medical history, fish allergy, infection risk, bleeding risk, pregnancy status, expectations and alternatives.

History
Consent
Aftercare
Review

Before treatment

Consultation: The journey begins with a thorough medical history assessment to rule out allergies, evaluate skin/tissue health, and establish realistic patient expectations.

During care

The Procedure: A topical numbing cream is generally applied before the procedure to effectively manage discomfort during the series of superficial injections.

Aftercare

Recovery: Mild, transient reactions such as localised redness, swelling, tenderness, and light bruising are a normal part of the healing process and generally resolve naturally within a few.

When to reassess

If symptoms persist, worsen or do not match expectations, reassessment is safer than repeating treatment automatically.

Practical expectations

Initial Protocol: A standard clinical course requires 2 to 3 sessions for skin treatments, and up to 5 sessions for intimate wellness, spaced 2 to 4 weeks apart.

Costs and treatment plans should be confirmed before booking; do not rely on generic package claims.





Common concerns and myths

Common misconceptions

Clear patient information should correct over-simple claims and keep expectations realistic.

Myth: polynucleotides are fillers

Reality: they are biostimulatory DNA fragments used for gradual tissue-quality support, not instant volume.

Myth: hormone-free means suitable for everyone

Reality: fish allergy, infection, bleeding, pregnancy, recent surgery and unclear pain can make treatment unsuitable.

Myth: results are promised

Reality: response varies and should be reviewed before repeating treatment.

Evidence and limits

Mechanism-of-action language should not be treated as proof of a predictable result.

Alternatives still matter

Moisturisers, local hormonal care, pelvic-floor physiotherapy, infection treatment or specialist review may be better for some patients.





Safety checklist

Safety checklist

Use these questions to decide whether treatment should be discussed, delayed or redirected.

Has the cause been assessed?

Symptoms should be reviewed in context before selecting an injectable treatment.

Are red flags absent?

Active infection, unexplained bleeding, severe pain or new vulval changes should be checked first.

Are alternatives clear?

Ask what conservative, hormonal, pelvic-floor or specialist options may be more appropriate.

Is follow-up planned?

The clinic should explain aftercare, review timing and when to seek help.

Reassuring signs

Proceeding is more reasonable when diagnosis is clear, goals are realistic, red flags are absent and aftercare is understood.

Clear diagnosis
No red flags
Review plan

Reasons to pause

Pause treatment for active infection, unexplained bleeding, pregnancy, severe fish allergy, recent pelvic surgery, severe pain or changing vulval skin.

Pain
Bleeding
Infection




When to escalate

When to seek medical help

Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online

Allergy symptoms

Swelling of the lips, tongue or face, breathing difficulty, widespread hives, faintness or collapse needs urgent help.

Bleeding or new skin change

New post-menopausal bleeding, ulcers, changing white plaques, unusual discharge or visible blood in urine should be assessed.

Infection signs

Fever, pus, spreading redness, worsening swelling or feeling unwell after a procedure needs prompt advice.

Emergency symptoms

Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Next step

Book a clinical consultation

A consultation can confirm whether intimate polynucleotides may be suitable, whether another pathway should come first, and what realistic outcomes, risks and aftercare would look like.

View Research Sources (12 Sources)
• Journal of Cosmetic Dermatology (2024): A systematic review evaluating 219 patients across nine studies, which confirmed statistically reported improvements in skin texture, elasticity, and wrinkle reduction.
• Aesthetic Medicine (2024): A clinical review documenting improved skin elasticity, hydration, and fine lines with minimal side effects following polynucleotide therapies. Cochrane Library / PubMed: Systematic reviews validating foundational treatments for GSM, establishing the evidence-based clinical context in which regenerative adjunct therapies like polynucleotides are applied.
• Interventional procedure overview of transvaginal laser therapy for urogenital atrophy - NICE
• Menopause: diagnosis and management | NICE
• Labiaplasty, vaginoplasty and hymenorrhaphy - NHS Cheshire and Merseyside
• Gynecoplastic Surgery: A Unified Terminology for Female Genital Aesthetic, Reconstructive, and Functional Procedures - PMC
• Polynucleotides in Aesthetic Medicine: A Review of Current Practices and Perceived Effectiveness - PMC
• Vaginal rejuvenation: current perspectives - PMC
• Printed list of National Trade marks accepted for opposition purposes as shown in Trade Marks Journal No 2026/003 published 16 J - Intellectual Property Office
• Aftercare for Polynucleotides Treatment | Skin Medical, Northwood
• Amazing Polynucleotides for Skin Rejuvenation - Riverbanks Clinic
• CE Marking Vs SCPN Vs CPNP: Why It Matters - Fox Pharma

These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 61 imported records. Additional reviewed material included clinical papers, guidance documents and patient-facing medical resources; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

Loading directory...